BIOMIND Trademark

Trademark Overview

On Friday, October 29, 2021, a trademark application was filed for BIOMIND with the United States Patent and Trademark Office. The USPTO has given the BIOMIND trademark a serial number of 97099616. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Monday, August 19, 2024. This trademark is owned by Biomind Labs Inc.. The BIOMIND trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical drug development services
biomind

General Information

Serial Number97099616
Word MarkBIOMIND
Filing DateFriday, October 29, 2021
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateMonday, August 19, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Description of MarkThe mark consists of the mark "BIOMIND" shown positioned relative to a brain, where the brain is formed up of connected circles.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesPharmaceutical drug development services

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, November 12, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBiomind Labs Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTortola VG1110
VG

Trademark Events

Event DateEvent Description
Tuesday, November 2, 2021NEW APPLICATION ENTERED
Friday, November 12, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, November 13, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, August 9, 2022ASSIGNED TO EXAMINER
Tuesday, August 9, 2022NON-FINAL ACTION WRITTEN
Tuesday, August 9, 2022NON-FINAL ACTION E-MAILED
Tuesday, August 9, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 9, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 9, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 9, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 21, 2023SUSPENSION LETTER WRITTEN
Tuesday, February 21, 2023LETTER OF SUSPENSION E-MAILED
Thursday, December 7, 2023SUSPENSION INQUIRY WRITTEN
Tuesday, February 21, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, September 29, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Thursday, December 7, 2023ASSIGNED TO EXAMINER
Thursday, December 7, 2023INQUIRY TO SUSPENSION E-MAILED
Thursday, December 7, 2023NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, March 5, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, March 5, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, March 5, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 19, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 19, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 19, 2024ASSIGNED TO LIE
Tuesday, March 5, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 5, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

biomind services development drug pharmaceutical